06 December 2003
Ann Transplant 2002; 7(3): 4-10 :: ID: 5547
Induction therapy for organ transplantation using monoclonal antibodies has been in recent years reevaluated. Results from various centers indicate the value of such therapy, especially in sensitized patients undergoing kidney transplantation as well as in simultaneous kidney--pancreas transplant patients. Author presents the experience of eleven years of intraoperative ATG bolus administration in the Berlin--Friedrichshain Kidney Transplantation Center.
11 Jan 2022 : Original articleEfficacy of Nitric Oxide-Releasing Nanofibers in Reducing Renal Ischemia-Reperfusion Injury in a Rat Model
Ann Transplant In Press; DOI: 10.12659/AOT.934800
Most Viewed Current Articles
29 Dec 2021 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588
22 Dec 2021 : Original articleComparison of Coronary Artery Calcium Scoring with Dobutamine Stress Echo for Detection of Coronary Artery ...
Ann Transplant 2021; 26:e934163
01 Dec 2021 : Original articleSolid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-S...
Ann Transplant 2021; 26:e934175